secwatch.observer — SEC 8-K summary
======================================

Issuer:     Accustem Sciences Inc. (ACUT)
CIK:        0001850767
Form:       8-K
Filed at:   2022-04-05T23:59:59+00:00
Accession:  0001493152-22-009142
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AccuStem Sciences sells 1.34M shares to Tiziana Life Sciences at $2.00/sh, raising $2.68M; CEO also joins board
--------------------------------------------------------------------------------

- Tiziana Life Sciences purchased 1,337,970 shares of AccuStem common stock at $2.00 per share for gross proceeds of $2,675,940.
- Sale was pursuant to a Supplemental Demerger Agreement from Oct 2021, requiring Tiziana to buy £2M shares at listing.
- Shares are unregistered and offered under Regulation S exemption.
- CEO Wendy Blosser appointed to the Board of Directors, effective March 30, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850767/000149315222009142/0001493152-22-009142-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850767/000149315222009142/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-009142

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer